Aquestive Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 http://www.monosolrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics Inc

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences - Jun 7th, 2019 6:30 am
Aquestive Therapeutics Completes Enrollment in Libervant™ (diazepam buccal film) Crossover Study - Jun 4th, 2019 6:00 am
Aquestive Therapeutics: 1Q Earnings Snapshot - May 8th, 2019 5:31 am
Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights - May 8th, 2019 5:00 am
IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil - May 8th, 2019 5:00 am
Aquestive Therapeutics Announces Daniel Barber Named to Chief Operating Officer - May 7th, 2019 5:00 pm
Need To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying Shares - Apr 26th, 2019 1:55 pm
Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019 - Apr 17th, 2019 3:17 pm
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS - Apr 16th, 2019 6:00 am
Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference - Mar 25th, 2019 2:25 pm
Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why - Mar 21st, 2019 7:00 am
Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights - Mar 14th, 2019 5:00 am
Aquestive Therapeutics to Present at Oppenheimer's 29th Annual Healthcare Conference - Mar 7th, 2019 12:34 pm
Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019 - Feb 19th, 2019 7:00 am
Aquestive Therapeutics to Present at 2019 BIO CEO & Investor Conference - Feb 8th, 2019 7:00 am
Aquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film Litigation - Feb 5th, 2019 6:00 am
Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application - Jan 31st, 2019 6:55 am
Aquestive Therapeutics Granted Temporary Restraining Order (TRO) Against Alvogen - Jan 25th, 2019 11:13 am